Company Filing History:
Years Active: 1989
Title: The Innovations of Jeffrey Edwards
Introduction
Jeffrey Edwards is a notable inventor based in Swansea, GB. He has made significant contributions to the field of biochemistry, particularly with his work on hyaluronidase. His innovative approach has led to advancements in pharmaceutical and veterinary formulations.
Latest Patents
Jeffrey Edwards holds a patent for a specific type of hyaluronidase. This hyaluronidase is a hyaluronic acid-specific endo-.beta.-glucuronidase, with a molecular weight of about 28,500 in its non-reduced form. It is derived from buffalo leeches, specifically from the sub-family Hirudinariinae, including species such as Hirudinaria manillensis and Poecilobdella granulosa. This enzyme cleaves hyaluronic acid without affecting chondroitin, chondroitin-4-sulphate, chondroitin-6-sulphate, or heparin. Notably, it exhibits greater stability at high temperatures and extreme pH levels compared to known leech hyaluronidase. The applications of this hyaluronidase are extensive, particularly in stimulating the flow of physiological fluids in the eye, which is beneficial in treating conditions like glaucoma.
Career Highlights
Jeffrey Edwards is currently associated with Biopharm (UK) Limited, where he continues to innovate in the field of biochemistry. His work has garnered attention for its potential applications in both human and veterinary medicine.
Collaborations
One of his notable collaborators is Roy T Sawyer, with whom he has worked on various projects related to his patent.
Conclusion
Jeffrey Edwards is a distinguished inventor whose work on hyaluronidase has the potential to impact medical treatments significantly. His contributions to the field highlight the importance of innovation in biochemistry.